Biomarkers associated with failure of liberation from oxygen therapy in severe covid-19: A pilot study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kweon, Oh Joo | - |
dc.contributor.author | Cha, Min Jae | - |
dc.contributor.author | Baek, Moon Seong | - |
dc.contributor.author | Choi, Seong-Ho | - |
dc.contributor.author | Kim, Won-Young | - |
dc.date.accessioned | 2023-03-08T10:26:52Z | - |
dc.date.available | 2023-03-08T10:26:52Z | - |
dc.date.issued | 2021-10 | - |
dc.identifier.issn | 2075-4426 | - |
dc.identifier.issn | 2075-4426 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/62151 | - |
dc.description.abstract | This study aimed to investigate whether clinical and laboratory biomarkers can identify patients with COVID-19 who are less likely to be liberated from oxygen therapy. This was a retrospective study comparing 18 patients in the weaning failure group with 38 patients in the weaning success group. Weaning failure was defined as death or discharge with an oxygen device before day 28 after hospital admission or requiring oxygen support as of day 28. The median quick Sequential Organ Failure Assessment (qSOFA) score was significantly higher and the median SpO2 /FiO2 was significantly lower in the weaning failure group. The laboratory biomarkers, procalcitonin (PCT) and D-dimer, were significantly higher in the weaning failure group, as were the biomarkers of endothelial injury, such as angiopoietin-2 (Ang-2) and Ang-2/Ang-1, and tumor necrosis factor-α (TNF-α). Patients’ qSOFA scores, SpO2 /FiO2, and PCT, D-dimer, Ang-2, Ang-2/Ang-1, endocan (4-day and 7-day increases), and TNF-α levels predicted weaning failure; 7-day endocan levels were the best predictor of weaning failure with an AUC of 0.81 (95% CI, 0.67–0.94). We identified clinical and laboratory parameters, including plasma biomarkers of endothelial injury, that may be considered as biomarkers for predicting failure of liberation from oxygen therapy in patients with severe COVID-19. © 2021 by the authors. Licensee MDPI, Basel, Switzerland. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | Biomarkers associated with failure of liberation from oxygen therapy in severe covid-19: A pilot study | - |
dc.type | Article | - |
dc.identifier.doi | 10.3390/jpm11100974 | - |
dc.identifier.bibliographicCitation | Journal of Personalized Medicine, v.11, no.10 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000712852900001 | - |
dc.identifier.scopusid | 2-s2.0-85116485724 | - |
dc.citation.number | 10 | - |
dc.citation.title | Journal of Personalized Medicine | - |
dc.citation.volume | 11 | - |
dc.type.docType | Article | - |
dc.publisher.location | 스위스 | - |
dc.subject.keywordAuthor | Angiopoietins | - |
dc.subject.keywordAuthor | Biomarkers | - |
dc.subject.keywordAuthor | COVID-19 | - |
dc.subject.keywordAuthor | Endocan | - |
dc.subject.keywordAuthor | SARS-CoV-2 | - |
dc.subject.keywordAuthor | Weaning | - |
dc.subject.keywordPlus | DISEASE 2019 COVID-19 | - |
dc.subject.keywordPlus | CLINICAL-OUTCOMES | - |
dc.subject.keywordPlus | SEPTIC SHOCK | - |
dc.subject.keywordPlus | CORONAVIRUS | - |
dc.subject.keywordPlus | PROCALCITONIN | - |
dc.subject.keywordPlus | PROTEIN | - |
dc.relation.journalResearchArea | Health Care Sciences & Services | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Health Care Sciences & Services | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.